Cholesterol treatment with statins: Who is left out and who makes it to goal?

نویسندگان

  • Peter Franks
  • Daniel Tancredi
  • Paul Winters
  • Kevin Fiscella
چکیده

BACKGROUND Whether patient socio-demographic characteristics (age, sex, race/ethnicity, income, and education) are independently associated with failure to receive indicated statin therapy and/or to achieve low density lipoprotein cholesterol (LDL-C) therapy goals are not known. We examined socio-demographic factors associated with a) eligibility for statin therapy among those not on statins, and b) achievement of statin therapy goals. METHODS Adults (21-79 years) participating in the United States (US) National Health and Nutrition Examination Surveys, 1999-2006 were studied. Statin eligibility and achievement of target LDL-C was assessed using the US Third Adult Treatment Panel (ATP III) on Treatment of High Cholesterol guidelines. RESULTS Among 6,043 participants not taking statins, 10.4% were eligible. Adjusted predictors of statin eligibility among statin non-users were being older, male, poorer, and less educated. Hispanics were less likely to be eligible but not using statins, an effect that became non-significant with adjustment for language usually spoken at home. Among 537 persons taking statins, 81% were at LDL-C goal. Adjusted predictors of goal failure among statin users were being male and poorer. These risks were not attenuated by adjustment for healthcare access or utilization. CONCLUSION Among person's not taking statins, the socio-economically disadvantaged are more likely to be eligible and among those on statins, the socio-economically disadvantaged are less likely to achieve statin treatment goals. Further study is needed to identify specific amenable patient and/or physician factors that contribute to these disparities.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Efficacy of apple cider vinegar and verjuice in the treatment of hyperlipidemia compared with lovastatin

Background: Hyperlipidemia and especially hypercholesterolemia is a known risk factor for cardiovascular morbidity and mortality. There are several types of drugs with different side effects, to lower blood lipid levels. Statins are the most commonly used drugs for treating high LDL cholesterol level. Apple cider vinegar and verjuice as old folk remedies claimed to have been beneficial in treat...

متن کامل

Cholesterol suppresses antimicrobial effect of statins

Objective(s):Isoprenoid biosynthesis is a key metabolic pathway to produce a wide variety of biomolecules such as cholesterol and carotenoids, which target cell membranes. On the other hand, it has been reported that statins known as inhibitors of isoprenoid biosynthesis and cholesterol lowering agents, may have a direct antimicrobial effect on the some bacteria. The exact action of statins in ...

متن کامل

Cholesterol levels and cholesterol lowering in idiopathic dilated cardiomyopathy.

We read with great interest the recent article of Dr Christ et al. about the prognostic significance of serum cholesterol levels in patients with idiopathic dilated cardiomyopathy (IDC). It was found that decreased cholesterol levels do not independently predict adverse prognosis in patients with IDC and that low cholesterol levels are dependent on the severity of the disease (i.e. higher NYHA ...

متن کامل

Therapy with statins is effective in some patients with homozygous familial hypercholesterolemia.

Patients with homozygous familial hypercholesterolemia have elevated markedly low-density lipoprotein (LDL) cholesterol levels that are refractory to commonly used doses of hypolipidemic drugs, including statin [1]. We read with great interest the recently published report by Raal et al. who showed that high doses of atorvastatin (80 mg/day) are effective in lowering LDL cholesterol by 28% in p...

متن کامل

I-22: Decision Trees for Identifying Predictor of Treatment Effectiveness in Clinical Trials and Its Application to Ovulation in a Study of Women with Polycystic Ovary Syndrome

Background: Double-blind, randomized clinical trials are the preferred approach to demonstrate the effectiveness of one treatment against another. The comparison is, however, made on the average group effects. While patients and clinicians have always struggled to understand why patients respond differently to the same treatment, and while much hope has been held out for the nascent field of pr...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 10  شماره 

صفحات  -

تاریخ انتشار 2010